North American Study for the Treatment of Recurrent Epistaxis with Doxycycline: The NOSTRIL trial

References

Page 1

	Year	Citations
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4) Carol J. Gallione, Gabriela M. Repetto, Eric Legius, The Lancet Mendelian DisorderGenetic DisorderGeneticsGenetic EpidemiologyPathology	2004	743
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia Marie E. Faughnan, Johannes J. Mager, Steven W. Hetts, Annals of Internal Medicine	2020	467
The Crossover Experiment for Clinical Trials Byron Wm. Brown Biometrics Experiment DesignStatisticsPatient SafetyClinical TrialsCarryover Effects	1980	374
An epistaxis severity score for hereditary hemorrhagic telangiectasia Jeffrey B. Hoag, Peter B. Terry, Sally E. Mitchell, The Laryngoscope	2010	261
Effects of Subantimicrobial-Dose Doxycycline in the Treatment of Moderate Acne Robert A. Skidmore, Rodney Kovach, Clay Walker, Archives of Dermatology	2003	238
Cross-Over Experiments: Design, Analysis and Application. Paul J. Smith, David A. Ratkowsky, Marc A. Evans, Journal of the American Statistical Association Variance BalanceEngineeringBasic PrinciplesExperiment DesignDesign	1994	169
Safety and Efficacy Review of Doxycycline Natasha E. Holmes, Patrick G. P. Charles Clinical Medicine Therapeutics Drug SafetyEfficacy ReviewOral Contraceptive PillAntibioticsTetracycline Class	2009	163
Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haneen Sadick, Frank Riedel, Ramin Naim, PubMed	2005	156
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study Hanny Al‐Samkari, Raj S. Kasthuri, Joseph G. Parambil, Haematologica	2020	136
Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease Ségolène Gaillard, Sophie Dupuis‐Girod, Florent Boutitie, Journal of Thrombosis and Haemostasis Rare DiseaseHematologyPathologyBleeding DisorderMedicine	2014	117

Page 1